| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Philippe Huot, Véronique Sgambato-Faure, Susan H Fox, Andrew C McCrear. Serotonergic Approaches in Parkinson's Disease: Translational Perspectives, an Update. ACS chemical neuroscience. vol 8. issue 5. 2018-02-07. PMID:28460160. |
5-ht has been shown to play a role in several motor and nonmotor manifestations of pd, including tremor, cognition, depression and psychosis. |
2018-02-07 |
2023-08-13 |
Not clear |
| Sho Moriguchi, Harumasa Takano, Yasuyuki Kimura, Tomohisa Nagashima, Keisuke Takahata, Manabu Kubota, Soichiro Kitamura, Tatsuya Ishii, Masanori Ichise, Ming-Rong Zhang, Hitoshi Shimada, Masaru Mimura, Jeffrey H Meyer, Makoto Higuchi, Tetsuya Suhar. Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2. The international journal of neuropsychopharmacology. vol 20. issue 12. 2018-02-01. PMID:29016875. |
duloxetine is a serotonin and norepinephrine reuptake inhibitor that has been widely used for the treatment of depression. |
2018-02-01 |
2023-08-13 |
human |
| George Anderson, Cathy Vaillancourt, Michael Maes, Russel J Reite. Breastfeeding and the gut-brain axis: is there a role for melatonin? Biomolecular concepts. vol 8. issue 3-4. 2018-01-31. PMID:28723608. |
as the melatonergic pathways are dependent on the levels of serotonin availability as a necessary precursor, decreased melatonin is linked to depression and depression-associated disorders. |
2018-01-31 |
2023-08-13 |
Not clear |
| Peng Wang, Hui Li, Swapnali Barde, Ming-Dong Zhang, Jing Sun, Tong Wang, Pan Zhang, Hanjiang Luo, Yongjun Wang, Yutao Yang, Chuanyue Wang, Per Svenningsson, Elvar Theodorsson, Tomas G M Hökfelt, Zhi-Qing David X. Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray. Proceedings of the National Academy of Sciences of the United States of America. vol 113. issue 32. 2018-01-29. PMID:27457954. |
the neuropeptide galanin coexists in rat brain with serotonin in the dorsal raphe nucleus and with noradrenaline in the locus coeruleus (lc), and it has been suggested to be involved in depression. |
2018-01-29 |
2023-08-13 |
rat |
| Li-Jun Zuo, Shu-Yang Yu, Yang Hu, Fang Wang, Ying-Shan Piao, Teng-Hong Lian, Qiu-Jin Yu, Rui-Dan Wang, Li-Xia Li, Peng Guo, Yang Du, Rong-Yan Zhu, Zhao Jin, Ya-Jie Wang, Xiao-Min Wang, Piu Chan, Sheng-Di Chen, Yong-Jun Wang, Wei Zhan. Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease. Scientific reports. vol 6. issue 1. 2018-01-29. PMID:28442790. |
in fatigue group, mental fatigue score is negatively correlated with 5-ht level in csf, and positively correlated with the scores of depression and excessive daytime sleepiness, and disease duration, also, mental fatigue is positively correlated with the levels of iron and transferrin in csf. |
2018-01-29 |
2023-08-13 |
Not clear |
| Andreas Heinz, Florian Schlagenhauf, Anne Beck, Carolin Wackerhage. Dimensional psychiatry: mental disorders as dysfunctions of basic learning mechanisms. Journal of neural transmission (Vienna, Austria : 1996). vol 123. issue 8. 2018-01-26. PMID:27145766. |
with respect to negative mood states, it has been shown that both reduced functional activation of the ventral striatum elicited by reward-predicting stimuli and stress-associated activation of the hypothalamic-pituitary-adrenal axis in interaction with reduced serotonin transporter availability and increased amygdala activation by aversive cues contribute to clinical depression; altogether these observations support the notion that basic learning mechanisms, such as pavlovian and instrumental conditioning and pavlovian-to-instrumental transfer, represent a basic dimension of mental disorders that can be mechanistically characterized using computational modeling and associated with specific clinical syndromes across established nosological boundaries. |
2018-01-26 |
2023-08-13 |
Not clear |
| Robert Z Wang, Vishal Vashistha, Sukhdeep Kaur, Nathan W Houchen. Serotonin syndrome: Preventing, recognizing, and treating it. Cleveland Clinic journal of medicine. vol 83. issue 11. 2018-01-25. PMID:27824534. |
as the use of serotonergic agents to treat depression has increased, so too has the incidence of serotonin syndrome. |
2018-01-25 |
2023-08-13 |
Not clear |
| Tobias Buchborn, Helmut Schröder, Volker Höllt, Gisela Grecksc. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling. Journal of psychopharmacology (Oxford, England). vol 28. issue 6. 2018-01-16. PMID:24785760. |
repeated lysergic acid diethylamide in an animal model of depression: normalisation of learning behaviour and hippocampal serotonin 5-ht2 signalling. |
2018-01-16 |
2023-08-13 |
rat |
| M Kellner, T Porseryd, I Porsch-Hällström, B Borg, C Roufidou, K H Olsé. Developmental exposure to the SSRI citalopram causes long-lasting behavioural effects in the three-spined stickleback (Gasterosteus aculeatus). Ecotoxicology (London, England). vol 27. issue 1. 2018-01-11. PMID:29058178. |
selective serotonin re-uptake inhibitors (ssris) are a class of psychotropic drugs used to treat depression in both adolescents and pregnant or breast-feeding mothers as well as in the general population. |
2018-01-11 |
2023-08-13 |
Not clear |
| Ramses Ribot, Bichun Ouyang, Andres M Kanne. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating? Epilepsy & behavior : E&B. vol 70. issue Pt A. 2018-01-09. PMID:28407526. |
selective serotonin re-uptake inhibitors (ssris) and serotonin-norepinephrine reuptake inhibitors (snris) are considered first-line treatment for primary depression and anxiety disorders. |
2018-01-09 |
2023-08-13 |
Not clear |
| Maya Amitai, Michal Taler, Miri Carmel, Elena Michaelovsky, Tamar Eilat, Maya Yablonski, Naama Orpaz, Alon Chen, Alan Apter, Abraham Weizman, Silvana Fenni. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders. Journal of child and adolescent psychopharmacology. vol 26. issue 8. 2018-01-05. PMID:26771135. |
the relationship between plasma cytokine levels and response to selective serotonin reuptake inhibitor treatment in children and adolescents with depression and/or anxiety disorders. |
2018-01-05 |
2023-08-13 |
Not clear |
| Maya Amitai, Michal Taler, Miri Carmel, Elena Michaelovsky, Tamar Eilat, Maya Yablonski, Naama Orpaz, Alon Chen, Alan Apter, Abraham Weizman, Silvana Fenni. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders. Journal of child and adolescent psychopharmacology. vol 26. issue 8. 2018-01-05. PMID:26771135. |
this is the first report, to our knowledge, of the relationship between response to selective serotonin reuptake inhibitor (ssri) treatment for anxiety and/or depression and cytokine levels in children and adolescents. |
2018-01-05 |
2023-08-13 |
Not clear |
| Al Amira Safa Shehab, David Brent, Fadi T Maalou. Neurocognitive Changes in Selective Serotonin Reuptake Inhibitors-Treated Adolescents with Depression. Journal of child and adolescent psychopharmacology. vol 26. issue 8. 2018-01-05. PMID:26974181. |
neurocognitive changes in selective serotonin reuptake inhibitors-treated adolescents with depression. |
2018-01-05 |
2023-08-13 |
Not clear |
| Al Amira Safa Shehab, David Brent, Fadi T Maalou. Neurocognitive Changes in Selective Serotonin Reuptake Inhibitors-Treated Adolescents with Depression. Journal of child and adolescent psychopharmacology. vol 26. issue 8. 2018-01-05. PMID:26974181. |
the current study aimed to investigate the changes in neurocognitive functioning in adolescents with depression during an acute treatment course with selective serotonin reuptake inhibitor. |
2018-01-05 |
2023-08-13 |
Not clear |
| Jaya Thomas, R Khanam, Divya Vohor. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway. Neurochemistry international. vol 99. 2018-01-03. PMID:27311540. |
venlafaxine, a serotonin norepinephrine reuptake inhibitor, is a widely prescribed drug in depression. |
2018-01-03 |
2023-08-13 |
mouse |
| Alberto Rubio-Casillas, Alonso Fernández-Guast. The dose makes the poison: from glutamate-mediated neurogenesis to neuronal atrophy and depression. Reviews in the neurosciences. vol 27. issue 6. 2018-01-02. PMID:27096778. |
the dysregulation of the glutamatergic transmission in depression could be underlined by several factors including a decreased inhibition (γ-aminobutyric acid or serotonin) or an increased excitation (primarily within the glutamatergic system). |
2018-01-02 |
2023-08-13 |
Not clear |
| William T Donnelly, Donald Bartlett, J C Leite. Serotonin in the solitary tract nucleus shortens the laryngeal chemoreflex in anaesthetized neonatal rats. Experimental physiology. vol 101. issue 7. 2018-01-02. PMID:27121960. |
thus, endogenous 5-ht released within the nts may curtail the respiratory depression that is part of the lcr, and serotonergic shortening of the lcr may be attributed to activation of 5-ht3 receptors within the nts. |
2018-01-02 |
2023-08-13 |
rat |
| S Vrshek-Schallhorn, V Sapuram, B M Aver. Letter to the Editor: Bias in the measurement of bias. Letter regarding 'Citation bias and selective focus on positive findings in the literature on the serotonin transporter gene (5-HTTLPR), life stress and depression'. Psychological medicine. vol 47. issue 1. 2018-01-01. PMID:27681844. |
letter regarding 'citation bias and selective focus on positive findings in the literature on the serotonin transporter gene (5-httlpr), life stress and depression'. |
2018-01-01 |
2023-08-13 |
Not clear |
| Keng-Fan Liu, Yingxiao Li, Kai Chun Cheng, Chao Chin Hsu, Juei-Tang Cheng, Wen-Huang Pen. Changes in PPARδ expression in a rat model of stress-induced depression. Clinical and experimental pharmacology & physiology. vol 44. issue 6. 2018-01-01. PMID:28267873. |
depression is a common mental disorder that has been linked to a decrease in the expression of serotonin and/or the serotonin transporter in the brain. |
2018-01-01 |
2023-08-13 |
rat |
| Keng-Fan Liu, Yingxiao Li, Kai Chun Cheng, Chao Chin Hsu, Juei-Tang Cheng, Wen-Huang Pen. Changes in PPARδ expression in a rat model of stress-induced depression. Clinical and experimental pharmacology & physiology. vol 44. issue 6. 2018-01-01. PMID:28267873. |
treatment with a pparδ agonist enhanced the expression of pparδ and the serotonin transporter in the hippocampus of rats with stress-induced depression. |
2018-01-01 |
2023-08-13 |
rat |